Overview
- 17 inspections across 17 sites are on record.
- 8 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2014-09-22.
At a glance
Inspections
17
Sites
17
Observations
8
Career since
Mar 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Genzyme A Sanofi Company | 22 Sep 2014 | Human Drugs | |
| Genzyme Corporation | 18 Sep 2014 | Human Drugs | |
| Masters Pharmaceuticals Inc. | 11 Aug 2014 | Human Drugs | |
| Ferring Controlled Therapeutics Ltd. | 13 Dec 2012 | ||
| Butterworth Laboratories Ltd | 5 Dec 2012 |
Sites inspected
Genzyme A Sanofi CompanyWaltham, United States1 insp.
Genzyme CorporationNorthborough, United States1 insp.
Masters Pharmaceuticals Inc.Fairfield, United States1 insp.
Ferring Controlled Therapeutics Ltd.Glasgow, United Kingdom1 insp.
Butterworth Laboratories LtdTeddington, United Kingdom1 insp.
Co-investigators
Investigators who share inspections with this person.
Tracey L Harris1 shared
Lindsey M Schwierjohann1 shared
Mary E Storch1 shared
Marianne Allen1 shared
Kathleen D Culver1 shared
Paul A Bonneau1 shared
Nicholas L Paulin1 shared
Full investigator report
Get the verbatim findings behind Mark E Parmon's 8 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site